Xilio Therapeutics XLO
NASDAQ XLO
$9.23 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Xilio Therapeutics (XLO) Total Debt (QoQ) (2021 - 2023)

Xilio Therapeutics (XLO) Total Debt (QoQ) (2021 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Xilio Therapeutics 178.33 Mn 42.29 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 -51.09%
Dec 31, 2022 -33.80%
Sep 30, 2022 -25.23%
Jun 30, 2022 -20.19%
Mar 31, 2022 -16.78%
Dec 31, 2021 0.50%